Reportlinker Adds The Ophthalmic Pharmaceutical Market Outlook To 2014 Competitive landscape pipeline analysis growth opportunities and market forecasts

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Non-Insulin Diabetes Management: Products, Players, Markets and Forecasts

Non-Insulin Diabetes Management: Products, Players, Markets and Forecasts

  • $ 3 850
  • Industry report
  • by Greystone Research Associates
  • May 2012

The diabetes market is changing. The convergence of environmental factors, lifestyle factors and increased patient longevity are driving double-digit growth projections for the incidence of non-insulin dependent (Type 2) diabetes globally. Type 2 diabetes accounts for about 90% of all diagnosed cases ...

Industries: Drug and Medication | Countries: Japan, Europe

Anesthesia Drugs Market (2011 - 2015) - U.S. Market Entry Study

Anesthesia Drugs Market (2011 - 2015) - U.S. Market Entry Study

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • May 2012
  • 164 pages

Anesthesia is a condition in which sensation is totally or partially blocked. This enables the patients to undergo medical procedures and surgery. Based on the applications (type of surgery or medical procedure) anesthetic drugs are broadly categorized into two types; i.e. local anesthetic drugs and ...

Industries: Drug and Medication | Countries: United States

Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management

Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management

  • $ 3 500
  • Industry report
  • by GBI Research
  • May 2012
  • 91 pages

Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management Summary GBI Research, the leading business intelligence provider, has released its latest research, ?Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to ...

Industries: Drug and Medication

Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs

Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs

  • $ 3 500
  • Industry report
  • by GBI Research
  • May 2012
  • 66 pages

Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs Summary GBI Research, the leading business intelligence provider, has released its latest research ?Drug Price Cuts in Top Five Countries ...

Industries: Drug and Medication | Countries: Europe

China Pharmaceutical & Medicine Mfg. Industry Profile

China Pharmaceutical & Medicine Mfg. Industry Profile

  • $ 580
  • Industry report
  • by Beijing Zeefer Consulting Ltd
  • May 2012
  • 24 pages

Through a comparative analysis on the development of pharmaceutical & medicine mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the pharmaceutical & medicine mfg. industry in China, a list of major 20 enterprises ...

Industries: Drug and Medication | Countries: China

China Chinese Prepared Medicines Mfg. Industry Profile

China Chinese Prepared Medicines Mfg. Industry Profile

  • $ 580
  • Industry report
  • by Beijing Zeefer Consulting Ltd
  • May 2012
  • 24 pages

Through a comparative analysis on the development of Chinese prepared medicines mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the Chinese prepared medicines mfg. industry in China, a list of major 20 enterprises ...

Industries: Drug and Medication | Countries: China

Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics

Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics

  • $ 399
  • Industry report
  • by La Merie Publishing
  • May 2012
  • 45 pages

Summary The present Competitive Intelligence Report about prophylaxis and therapy of S. aureus infections provides a competitor evaluation in the field of molecules for prevention or treatment of Staphylococcus aureus infections as of May 2012. Purchase of the downloadable pdf report includes a 6-month ...

Industries: Drug and Medication

Pathology in United States: Boehringer Ingelheim GmbH - Product Pipeline Review - H2 2011

Pathology in United States: Boehringer Ingelheim GmbH - Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 285 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industries Direct's proprietary databases, Boehringer Ingelheim GmbH's corporate website, SEC ...

Industries: Drug and Medication | Countries: World

Pharmaceutical in United States: Dainippon Sumitomo Pharma Co., Ltd. ? Product Pipeline Review - H2 2011

Pharmaceutical in United States: Dainippon Sumitomo Pharma Co., Ltd. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 152 pages

Ltd - Product Pipeline Review - H2 2011? provides a detailed overview on the Dainippon Sumitomo Pharma Co., Ltd's research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is ...

Industries: Drug and Medication

Drug Discovery and Development Industry: Dr. Reddy%s Laboratories Limited - Product Pipeline Review - Q1 2011

Drug Discovery and Development Industry: Dr. Reddy%s Laboratories Limited - Product Pipeline Review - Q1 2011

  • $ 500
  • Company report
  • by Global Markets Direct
  • May 2012
  • 134 pages

Dr. Reddy's Laboratories Limited - Product Pipeline Review - Q1 2011 pharmaceuticals report, ?Dr. Reddy's Laboratories Limited - Product Pipeline Review - Q1 2011? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, ...

Industries: Drug and Medication | Countries: India, United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • 00 1 718 213 49 04

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.